These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10338458

  • 1. Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibition.
    Elkayam U, Johnson JV, Shotan A, Bokhari S, Solodky A, Canetti M, Wani OR, Karaalp IS.
    Circulation; 1999 May 25; 99(20):2652-7. PubMed ID: 10338458
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial.
    Mahmarian JJ, Moyé LA, Chinoy DA, Sequeira RF, Habib GB, Henry WJ, Jain A, Chaitman BR, Weng CS, Morales-Ballejo H, Pratt CM.
    Circulation; 1998 May 26; 97(20):2017-24. PubMed ID: 9610531
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE, Ziesche S, Carson PE, Conrad CH, Syat D, Cohn JN.
    Am J Cardiol; 1996 May 15; 77(12):1078-82. PubMed ID: 8644661
    [Abstract] [Full Text] [Related]

  • 7. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ, Freestone S, Allen MJ, Muirhead GJ.
    Am J Cardiol; 1999 Mar 04; 83(5A):21C-28C. PubMed ID: 10078539
    [Abstract] [Full Text] [Related]

  • 8. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM, Berk MR, Brozena SC, Elkayam U, Plehn JF, Kukin ML, Packer M, Murphy BE, Neuberg GW, Steingart RM.
    Circulation; 1993 Aug 04; 88(2):492-501. PubMed ID: 8339411
    [Abstract] [Full Text] [Related]

  • 9. Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina.
    Parker JD, Parker AB, Farrell B, Parker JO.
    Circulation; 1996 Feb 15; 93(4):691-6. PubMed ID: 8640997
    [Abstract] [Full Text] [Related]

  • 10. Combined treatment with losartan and an ACE inhibitor in mild to moderate heart failure: results of a double-blind, randomized, placebo-controlled trial.
    Houghton AR, Harrison M, Cowley AJ, Hampton JR.
    Am Heart J; 2000 Nov 15; 140(5):e25. PubMed ID: 11054627
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB, Dunlap ME, Pfeffer MA, Probstfield JL, Cohen-Solal A, Dietz R, Granger CB, Hradec J, Kuch J, McKelvie RS, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Held P, Solomon SD, Yusuf S, Swedberg K, Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Investigators and Committees.
    Circulation; 2004 Oct 26; 110(17):2618-26. PubMed ID: 15492298
    [Abstract] [Full Text] [Related]

  • 14. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
    van Veldhuisen DJ, Genth-Zotz S, Brouwer J, Boomsma F, Netzer T, Man In 'T Veld AJ, Pinto YM, Lie KI, Crijns HJ.
    J Am Coll Cardiol; 1998 Dec 26; 32(7):1811-8. PubMed ID: 9857856
    [Abstract] [Full Text] [Related]

  • 15. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
    Skvortsov AA, Mareev VIu, Nasonova SN, Sychev AV, Arbolishvili GN, Baklanova NA, Masenko VP, Belenkov IuN.
    Ter Arkh; 2006 Dec 26; 78(8):14-20. PubMed ID: 17078211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Addition of candesartan to angiotensin converting enzyme inhibitor therapy in patients with chronic heart failure does not reduce levels of oxidative stress.
    Ellis GR, Nightingale AK, Blackman DJ, Anderson RA, Mumford C, Timmins G, Lang D, Jackson SK, Penney MD, Lewis MJ, Frenneaux MP, Morris-Thurgood J.
    Eur J Heart Fail; 2002 Mar 26; 4(2):193-9. PubMed ID: 11959049
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
    Volpe M, Tritto C, DeLuca N, Rubattu S, Mele AF, Lembo G, Enea I, deCampora P, Rendina V, Romano M.
    Circulation; 1992 Dec 26; 86(6):1800-9. PubMed ID: 1451252
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.